Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Companyâs principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.

Employees

1,073

Sector

Pharmaceuticals

Calendar

2025-02-05 - Q3 2025 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
24-12-09	6.410 $	+0.79%	474,914
24-12-06	6.360 $	+4.26%	415,515
24-12-05	6.100 $	-0.49%	461,099
24-12-04	6.130 $	-1.13%	246,843
24-12-03	6.200 $	-4.62%	357,302

Delayed Quote Toronto S.E., December 06, 2024 at 04:00 pm

More quotes

Income Statement and Estimates

income-statement-evolution-chart AURORA-CANNABIS-INC

More financial data

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

6.360CAD

Average target price

9.200CAD

Spread / Average Target

+44.65%

Consensus

Profit revisions

estimates-change-chart AURORA-CANNABIS-INC

Estimate revisions

Quarterly revenue - Rate of surprise

quality-estimates-chart AURORA-CANNABIS-INC

Company calendar

Delayed Toronto S.E. Other stock markets 13:57:20 2024-12-09 EST			5-day change	1st Jan Change
6.410 ^CAD	+0.79%		-1.38%	-1.38%

11-26	Aurora Cannabis Brief: Announcing Medical Product Advancements from Leading Cannabis Research Facility	MT
11-20	Aurora Cannabis Brief: Expanding Recreational Product Portfolio; Introduces New Products and Flavours across Greybeard, San Rafael '71 and Tasty's brands	MT

Capitalization	349M 247M 233M 216M 194M 20.89B 386M 2.69B 996M 8.58B 927M 906M 36.99B	P/E ratio 2025 *	-42.4x	P/E ratio 2026 *	45.4x
Enterprise value	349M 247M 233M 216M 194M 20.89B 386M 2.69B 996M 8.58B 927M 906M 36.99B	EV / Sales 2025 *	1.06x	EV / Sales 2026 *	0.97x
Free-Float	100%	Yield 2025 *	-	Yield 2026 *	-

Aurora Cannabis Brief: Announcing Medical Product Advancements from Leading Cannabis Research Facility	11-26	MT
Aurora Cannabis Brief: Expanding Recreational Product Portfolio; Introduces New Products and Flavours across Greybeard, San Rafael '71 and Tasty's brands	11-20	MT
Aurora Cannabis Inc. Expands Innovative Recreational Product Portfolio	11-20	CI
Aurora Cannabis Inc., Q2 2025 Earnings Call, Nov 06, 2024	11-06
Aurora Cannabis Q2 Profit Advances	11-06	MT
Aurora Cannabis Posts Q2 2025 Revenue of $81.1 Million, Up From $63.1 Million in Q2 2024	11-06	MT
Aurora Cannabis Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	11-06	CI
Aurora Cannabis Brief: Maintains Strong Balance Sheet with Near $152 Million of Cash and a Debt-Free Cannabis Business	11-06	MT
Aurora Cannabis Brief: Re-Affirms Target of Positive Free Cash Flow in the Quarter Ending December 31, 2024	11-06	MT
Aurora Cannabis Brief: Q2 Net Revenue up 29% YoY to $81.1 Million, with 41% growth in Global Medical Cannabis	11-06	MT
Aurora Cannabis Inc. Provides Earnings Guidance for the Third Quarter of Fiscal Year 2025	11-06	CI
Pot stocks dive as Florida rejects legalization of recreational marijuana	11-06	RE
Aurora Cannabis Down Slightly in U.S. Pre-Market After Reporting Project Collaboration Focused on Distinct Cannabis Aromas	10-02	MT

Canaccord Genuity Upgrades Aurora Cannabis to Buy From Hold	02-09	MT
CIBC Adjusts Aurora Cannabis Price Target to CA$1 From CA$1.75, Maintains Neutral Rating	23-06-16	MT
Aurora Cannabis Price Target Lowered to $1 at CIBC	23-06-16	MT
Aurora Cannabis Target Price Lowered to $1.75 at CIBC	23-02-10	MT
Piper Sandler Cuts Price Target on Aurora Cannabis to $1 From $2, Maintains Neutral Rating	22-12-28	MT

Aurora Cannabis Inc. Stock

Equities

ACB

CA05156X8504

Pharmaceuticals

Valuation: Aurora Cannabis Inc.

Chart: Aurora Cannabis Inc.

Latest news: Aurora Cannabis Inc.

Last Transcript: Aurora Cannabis Inc.

Analysts' recommendations: Aurora Cannabis Inc.

Press Releases: Aurora Cannabis Inc.

News in other languages: Aurora Cannabis Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Aurora Cannabis Inc.

Alternative Medicine

Financials

Company Profile

Quotes

Income Statement and Estimates

Ratings

Analysts' Consensus

Quarterly revenue - Rate of surprise

Aurora Cannabis : 2025 Q2 Management Discussion & Analysis	11-06	PU
Aurora Cannabis : 2025 Q2 Financial Statements	11-06	PU
Aurora Cannabis : IR presentation FY25 Q2 Final	11-06	PU
Aurora Cannabis : Announces Fiscal 2025 Second Quarter Results Form 6 K	11-06	PU
Aurora Cannabis : Condensed Consolidated Interim Financial Statements Form 6 K	11-06	PU

Cannabis: Die Branche schwebt wieder auf Wolke sieben	23-09-02
Cannabis: El sector vuelve a dispararse	23-09-01
Cannabis : le secteur plane à nouveau	23-09-01
UN-Drogenkontrollrat warnt Deutschland vor Cannabis-Legalisierung	23-03-09
Aktien von Cannabis-Anbieter Cantourage heben bei Debüt ab	22-11-11

1 day	+4.26%
1 week	-0.47%
Current month	-0.47%
1 month	-4.79%
3 months	-13.23%
6 months	-18.88%
Current year	-2.15%

Director	Title	Age	Since
Miguel Martin CEO	Chief Executive Officer	52	2020-09-07
Simona King DFI	Director of Finance/CFO	52	2024-02-20
Dave Aird CTO	Chief Tech/Sci/R&D Officer	-	-

Manager	Title	Age	Since
Michael Singer CHM	Chairman	59	2016-05-19
Norma Beauchamp BRD	Director/Board Member	63	2018-07-24
Ronald Funk CHM	Chairman	67	2021-05-12

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
AURORA CANNABIS INC.	+4.26%	-0.47%	-10.42%	-92.36%	247M
DONG-E-E-JIAO CO.,LTD.	+0.12%	-0.73%	+14.61%	+31.90%	5.08B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	+1.19%	-1.16%	-31.67%	+3.47%	3.91B
TASLY PHARMACEUTICAL GROUP CO., LTD	+0.83%	-0.68%	-7.56%	+5.21%	2.99B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+0.91%	-0.71%	-7.48%	+22.96%	2.94B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	+1.73%	+1.48%	-2.73%	-7.62%	2.51B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	+0.95%	+4.19%	-3.20%	-1.63%	1.75B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	-2.03%	+1.69%	+33.63%	+75.89%	1.72B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.58%	-1.18%	-3.55%	-15.33%	1.64B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+0.84%	-1.81%	+71.17%	+109.96%	1.59B
Average	+0.94%	-0.83%	+5.28%	+13.24%	2.44B
Weighted average by Cap.	+0.67%	-1.02%	+2.30%	+20.29%

	2025 *	2026 *
Net sales	329M 233M 220M 204M 183M 19.71B 364M 2.54B 939M 8.1B 874M 855M 34.9B	360M 255M 241M 224M 200M 21.58B 399M 2.78B 1.03B 8.87B 957M 936M 38.2B
Net income	-9.07M -6.42M -6.07M -5.63M -5.03M -543M -10.04M -70.05M -25.9M -223M -24.11M -23.57M -962M	8.21M 5.81M 5.49M 5.09M 4.55M 492M 9.09M 63.37M 23.43M 202M 21.81M 21.32M 870M
Net Debt	-	-